BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 17350960)

  • 1. Protein kinase C delta is required for survival of cells expressing activated p21RAS.
    Xia S; Forman LW; Faller DV
    J Biol Chem; 2007 May; 282(18):13199-210. PubMed ID: 17350960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1.
    Xia S; Chen Z; Forman LW; Faller DV
    Cell Signal; 2009 Apr; 21(4):502-8. PubMed ID: 19146951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
    Wert MM; Palfrey HC
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
    Jeay S; Pianetti S; Kagan HM; Sonenshein GE
    Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines.
    Liou JS; Chen JS; Faller DV
    J Cell Physiol; 2004 Feb; 198(2):277-94. PubMed ID: 14603530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.
    Chen Z; Forman LW; Miller KA; English B; Takashima A; Bohacek RA; Williams RM; Faller DV
    Endocr Relat Cancer; 2011 Dec; 18(6):759-71. PubMed ID: 21990324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
    Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P
    Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
    He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
    Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons.
    Xue L; Murray JH; Tolkovsky AM
    J Biol Chem; 2000 Mar; 275(12):8817-24. PubMed ID: 10722727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
    Lin CS; Lin FY; Ho LJ; Tsai CS; Cheng SM; Wu WL; Huang CY; Lian CH; Yang SP; Lai JH
    Cardiovasc Res; 2012 Aug; 95(3):346-55. PubMed ID: 22687273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
    Ksionda O; Mues M; Wandler AM; Donker L; Tenhagen M; Jun J; Ducker GS; Matlawska-Wasowska K; Shannon K; Shokat KM; Roose JP
    PLoS One; 2018; 13(5):e0193849. PubMed ID: 29799846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular transformation and activation of the phosphoinositide-3-kinase-Akt cascade by the ETV6-NTRK3 chimeric tyrosine kinase requires c-Src.
    Jin W; Yun C; Hobbie A; Martin MJ; Sorensen PH; Kim SJ
    Cancer Res; 2007 Apr; 67(7):3192-200. PubMed ID: 17409427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.
    Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ
    Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo.
    Chen Z; Forman LW; Williams RM; Faller DV
    BMC Cancer; 2014 Feb; 14():90. PubMed ID: 24528676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.
    Ohm AM; Tan AC; Heasley LE; Reyland ME
    Oncogene; 2017 Jul; 36(30):4370-4378. PubMed ID: 28368426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
    Genot E; Reif K; Beach S; Kramer I; Cantrell D
    Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
    Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
    Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric cyclic interferon-α2b peptide induces apoptosis by sequential activation of phosphatidylinositol 3-kinase, protein kinase Cδ and p38 MAP kinase.
    Blank VC; Bertucci L; Furmento VA; Peña C; Marino VJ; Roguin LP
    Exp Cell Res; 2013 Jun; 319(10):1471-81. PubMed ID: 23562842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.